Arcturus Therapeutics Holdings Inc. ·

ARCT 8-K 2026-08-25

Arcturus Therapeutics Holdings Inc. (ARCT) 8-K dated 2026-08-25 — accession 0001193805-26-001130. This URL is the filing, not the ARCT hub.

Arcturus Therapeutics Holdings Inc. (ARCT) is a biotechnology company listed on US.

Arcturus Therapeutics Holdings Inc. filed a 8-K on 2026-08-25. Accession 0001193805-26-001130.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.

Not investment advice. The ARCT SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR